Search results for "chorea"

showing 10 items of 12 documents

New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients

2017

Abstract Introduction The diagnosis aceruloplasminemia is usually made in patients with advanced neurological manifestations of the disease. In these patients prognosis is poor, disabilities are severe and patients often die young. The aim of our study was to facilitate recognition of aceruloplasminemia at a disease stage at which treatment can positively influence outcome. Currently, the neurological phenotype of aceruloplasminemia has been mainly described in Japanese patients. This ‘classical’ phenotype consists of cerebellar ataxia, hyperkinetic movement disorders and cognitive decline. In this study we describe the spectrum of neurological disease in Caucasian patients. Methods Data on…

0301 basic medicineAdultMalemedicine.medical_specialtyPediatricsAtaxiaMovement disordersBiologyWhite People03 medical and health sciencesNeurological manifestation0302 clinical medicinePhenotypic variabilitymedicineAceruloplasminemiaHumansCognitive declineAceruloplasminemiaPsychiatryDystoniaCerebellar ataxiaParkinsonismCeruloplasminChoreaNeurodegenerative DiseasesMiddle Agedmedicine.diseaseIron Metabolism DisordersPedigree030104 developmental biologyPsychiatric changesPhenotypeNeurologyFemaleNeurology (clinical)Geriatrics and Gerontologymedicine.symptomNervous System DiseasesSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' Motorie030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

NKX2-1 New Mutation Associated With Myoclonus, Dystonia, and Pituitary Involvement

2018

Background: NKX2-1 related disorders (also known as brain-lung-thyroid syndrome or benign hereditary chorea 1) are associated with a wide spectrum of symptoms. The core features are various movement disorders, characteristically chorea, less frequently myoclonus, dystonia, ataxia; thyroid disease; and lung involvement. The full triad is present in 50% of affected individuals. Numerous additional symptoms may be associated, although many of these were reported only in single cases. Pituitary dysfunction was ambiguously linked to NKX2-1 haploinsufficiency previously. Case Presentation: We examined two members of a family with motor developmental delay, mixed movement disorder (myoclonus, dyst…

0301 basic medicinePediatricsmedicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesMovement disordersAtaxialcsh:QH426-470NKX2-1 geneCase Reportbenign hereditary choreapituitary03 medical and health sciences0302 clinical medicineBenign hereditary choreamyoclonus dystoniaHypogonadotropic hypogonadismmedicineGeneticschoreaGenetics (clinical)Dystoniabusiness.industryChoreabrain-lung-thyroid syndromemedicine.diseasenervous system diseaseslcsh:Genetics030104 developmental biologyNKX2-1 related disordersempty sellaMolecular Medicinemedicine.symptombusinessHaploinsufficiencyMyoclonus030217 neurology & neurosurgeryFrontiers in Genetics
researchProduct

Hemichorea associated with varicella-zoster reinfection and endocarditis. A case report.

1985

A 20-year-old woman developed transient right-sided hemichoreatic movements after household exposure to varicella-zoster. Some days before the appearance of involuntary movements a vesicular rash had occurred. About 6 months later an elevated IgG serum titer against varicella virus was found and two-dimensional echocardiography showed signs of an endocarditis. During the following 2 months the IgG value returned to within the normal range and the choreatic movements disappeared almost totally. The possibility is discussed that endocarditis had been caused and maintained by serum antibodies to varicella-zoster virus which cross-reacted with valvular tissue. Embolization to the region of the …

AdultMyoclonusmedicine.medical_specialtyHerpesvirus 3 HumanHeart diseasevirusesmedicine.medical_treatmentAntibodies ViralGastroenterologyHerpes ZosterVirusFunctional LateralityChoreaInternal medicinemedicineEndocarditisHumansPharmacology (medical)EmbolizationAthetosisBiological PsychiatryEndocarditisbusiness.industryGeneral Neurosciencevirus diseasesChoreaGeneral Medicinemedicine.diseaseSurgeryPsychiatry and Mental healthTiterNeuropsychology and Physiological PsychologyEchocardiographyImmunoglobulin GFemaleViral diseasemedicine.symptombusinessEncephalitisEuropean archives of psychiatry and neurological sciences
researchProduct

Clinical spectrum of movement disorders after stroke in childhood and adulthood.

2011

Although rare, many different types of hyperkinetic and hypokinetic movement disorders have been described after both ischemic and hemorrhagic stroke in children and in adults. Current knowledge about these disorders comes from single case reports or small series of cases compiled from retrospective studies. Data from hospital-based studies suggest a prevalence of poststroke movement disorders ranging from 1.1 to 3.9%. However, despite the development of emergency care for stroke, these clinical syndromes remain insufficiently recognized. Poststroke movement disorders take place in the acute phase or following a variable delay after stroke onset, and could be transient or persistent. Dyston…

DystoniaAdultmedicine.medical_specialtyPediatricsMovement disordersMovement Disordersbusiness.industryChoreaRetrospective cohort studymedicine.diseaseStrokeNeurologyBasal gangliaPhysical therapymedicineHumansNeurology (clinical)medicine.symptombusinessChildStrokeMyoclonusAsterixisEuropean neurology
researchProduct

Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

2021

Background and ObjectivesAnti-IgLON5 disease is a recently described neurologic disease that shares features of autoimmunity and neurodegeneration. Abnormal movements appear to be frequent and important but have not been characterized and are underreported. We describe the frequency and types of movement disorders in a series of consecutive patients with this disease.MethodsIn this retrospective, observational study, the presence and phenomenology of movement disorders were assessed with a standardized clinical questionnaire. Available videos were centrally reviewed by 3 experts in movement disorders.ResultsSeventy-two patients were included. In 41 (57%), the main reason for initial consult…

DystoniaPediatricsmedicine.medical_specialtyAtaxiaMovement disordersbusiness.industryautoimmunityAnti-IgLON5neurodegenerationChoreamedicine.diseaseAkathisianervous system diseasesmedicineBody regionHuman medicineNeurology (clinical)Myokymiamedicine.symptombusinessMyoclonusResearch Article
researchProduct

Novel Mutations in the NKX2.1 gene and the PAX8 gene in a Boy with Brain-Lung-Thyroid Syndrome

2017

Abstract Objective To elucidate the molecular mechanism which causes thyroid dysgenesis (TD) in a boy with brain-lung-thyroid syndrome. Design, patients, measurements We describe a patient with TD, respiratory disease and cerebral palsy who is heterozygous for mutations in two different genes, the PAX8 (p.E234K) and the NKX2.1 (p.A329GfsX108). In vitro studies were performed to functionally characterize these mutations. Congenital hypothyroidism (CH) was identified by neonatal screening associated with a hypoplastic thyroid gland. Postpartum he developed a brain-lung-thyroid syndrome with severe respiratory failure, symptomatic epilepsy and a considerable psychomotor retardation. The DNA-bi…

Male0301 basic medicineCandidate geneEndocrinology Diabetes and MetabolismThyroid Nuclear Factor 1030105 genetics & heredityBiologymedicine.disease_causeThyroid dysgenesisPAX8 Transcription Factor03 medical and health sciencesEndocrinologyChoreaCongenital HypothyroidismInternal MedicinemedicineHumansChildAthetosisGeneRespiratory Distress Syndrome NewbornMutationPsychomotor retardationGeneral Medicinemedicine.diseasePhenotypeCongenital hypothyroidismMutationCancer researchmedicine.symptomPAX8Experimental and Clinical Endocrinology & Diabetes
researchProduct

Elevated serum triiodothyronine and intellectual and motor disability with paroxysmal dyskinesia caused by a monocarboxylate transporter 8 gene mutat…

2008

Monocarboxylate transporter 8 (MCT8 or SLC16A2) is important for the neuronal uptake of triiodothyronine (T3) in its function as a specific and active transporter of thyroid hormones across the cell membrane, thus being essential for human brain development. We report on a German male with Allan-Herndon-Dudley syndrome presenting with severe intellectual and motor disability, paroxysmal dyskinesia combined with truncal muscular hypotonia, and peripheral muscular hypertonia at his current age of 9 years. Additionally, the patient has a lesion in the left putamen region revealed by magnetic resonance imaging and elevated serum T3 levels. The male appeared to have a hemizygous mutation (R271H)…

MaleMonocarboxylic Acid Transportersmedicine.medical_specialtyDevelopmental DisabilitiesDNA Mutational AnalysisEnzyme-Linked Immunosorbent AssayGene mutationArginineLesionDevelopmental NeuroscienceChoreaInternal medicineIntellectual DisabilitymedicineHumansHistidineChildMonocarboxylate transporterAllan–Herndon–Dudley syndromeTriiodothyroninebiologyMuscular hypotoniaSymportersParoxysmal dyskinesiamedicine.diseaseMagnetic Resonance ImagingEndocrinologyPediatrics Perinatology and Child HealthMutationbiology.proteinHypertoniaTriiodothyronineNeurology (clinical)medicine.symptomDevelopmental medicine and child neurology
researchProduct

L26 The Role Of Occupational Therapy In Huntington's Disease

2014

Background We discuss the role of the occupational therapist working with individuals and families affected by Huntington’s disease. Objectives A research by purposes was carried out through the design and implementation of an intervention program aimed at preventing and alleviating the deterioration caused by the disease through training in daily living activities and cognitive stimulation, and coaching the families through monthly monitoring and annual meetings. Method A literature review using structured databases was conducted to identify studies focusing on Occupational Therapy in Huntington’s disease. An intervention program based on the different types, symptoms and stages of the dis…

Occupational therapyGerontologyProgram evaluationmedicine.medical_specialtyActivities of daily livingbusiness.industryChoreaDiseasemedicine.diseaseCoachingPsychiatry and Mental healthHuntington's diseaseIntervention (counseling)MedicineSurgeryNeurology (clinical)medicine.symptombusinessPsychiatryJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports

2017

Abstract Background Anti-N-methyl-D-aspartate receptor encephalitis is a rare autoimmune disease characterized by severe neurological and psychiatric symptoms and a difficult diagnosis. The disease is often secondary to a neoplastic lesion, seldom diagnosed years later. Psychiatric symptoms are prevalent in adults; neurologic symptoms are more evident in children, who typically present primarily with neurological symptoms. To the best of our knowledge, the association with juvenile idiopathic arthritis has not been described. Case presentation We report the cases of two caucasian girls with an atypical presentation. The first patient was an 8-year-old girl with normal psychomotor developmen…

PediatricsPathologyChoreiform movementAnti-Inflammatory AgentsArthritislcsh:MedicineCase ReportDisease0302 clinical medicinePrednisoneChildOvarian Neoplasms030219 obstetrics & reproductive medicineMedicine (all)Remission InductionTeratomaImmunoglobulins IntravenousGeneral MedicineMagnetic Resonance ImagingTreatment OutcomeMethylprednisoloneFemaleHip JointTeratomamedicine.symptomEncephalitismedicine.drugmedicine.medical_specialtyAdolescentAnti-N-methyl-D-aspartate receptor encephalitis; Chorea; Juvenile idiopathic arthritis; Psychiatric symptoms; Speech disorders; Teratoma; Medicine (all)Methylprednisolone03 medical and health sciencesJuvenile idiopathic arthritiChoreaPsychiatric symptomsmedicineHumansImmunologic FactorsAnti-N-methyl-D-aspartate receptor encephalitis; Chorea; Juvenile idiopathic arthritis; Psychiatric symptoms; Speech disorders; TeratomaAnti-N-methyl-D-aspartate receptor encephalitis; Chorea; Juvenile idiopathic arthritis; Psychiatric symptoms; Speech disorders; Teratoma; Adolescent; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Arthritis Infectious; Child; Female; Hip Joint; Humans; Immunoglobulins Intravenous; Immunologic Factors; Magnetic Resonance Imaging; Methylprednisolone; Ovarian Neoplasms; Remission Induction; Teratoma; Treatment Outcome; Medicine (all)Speech disorderSpeech disordersArthritis InfectiousPsychiatric symptombusiness.industrylcsh:RChoreaJuvenile idiopathic arthritismedicine.diseaseAnti-N-methyl-D-aspartate receptor encephalitisbusiness030217 neurology & neurosurgeryAnti-N-methyl-D-aspartate receptor encephaliti
researchProduct

Levetiracetam in the treatment of vascular chorea: a case report

2004

PharmacologyLevetiracetam Hemichoreabusiness.industryPharmacology toxicologyChoreaGeneral MedicineBioinformaticsMedicinePharmacology (medical)Levetiracetammedicine.symptombusinessAdverse effectmedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct